Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial*
- 1 March 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 37 (3), 803-810
- https://doi.org/10.1097/ccm.0b013e3181962316
Abstract
The impact of continuous venovenous hemofiltration on sepsis-induced multiple organ failure severity is controversial. We sought to assess the effect of early application of hemofiltration on the degree of organ dysfunction and plasma cytokine levels in patients with severe sepsis or septic shock.Prospective, randomized, open, multicenter study setting, 12 French intensive care units.A total of 80 patients were enrolled within 24 hours of development of the first organ failure related to a new septic insult.Patients were randomized to group 1 (HF), who received hemofiltration (25 mL/kg/hr) for a 96-hour period, or group 2 (C) who were managed conventionally.The primary end point was the number, severity, and duration of organ failures during 14 days, as evaluated by the Sepsis-Related Organ Failure Assessment score, on an intention-to-treat analysis. Strict guidelines were provided to perform continuous hemofiltration under the same conditions and bearing the same objectives in all centers. Because of inclusion stagnation, the trial was discontinued after an interim analysis by which time 76 patients had been randomized. The number and severity of organ failures were significantly higher in the HF group (p < 0.05). No modifications in plasma cytokine levels could be detected.These data suggest that early application of standard continuous venovenous hemofiltration is deleterious in severe sepsis and septic shock. This study does not rule out an effect of high-volume hemofiltration (>35 mL/kg/hr) on the course of sepsis.Keywords
This publication has 34 references indexed in Scilit:
- Serum IL‐6 and IL‐1‐ra with sequential organ failure assessment scores in septic patients receiving high‐volume haemofiltration and continuous venovenous haemofiltrationNephrology, 2006
- Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure*Critical Care Medicine, 2006
- Cytokine and endotoxin removal in critically Ill patientsTherapeutic Apheresis and Dialysis, 2005
- Septic shockThe Lancet, 2005
- Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia*Critical Care Medicine, 2004
- Plasmapheresis in SepsisPublished by S. Karger AG ,2004
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shockCritical Care Medicine, 2003
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patientsCritical Care Medicine, 1993